Skip to content

Clinical trials

Phase 2 Neuralgia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 2 Country / region: Poland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20122
20141
20172
20182
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aziende Chimiche Riunite Angelini Francesco S.p.A2
Novartis Pharmaceuticals2
Astellas Pharma Europe B.V.1
AstraZeneca1
Bayer1
Eli Lilly and Company1
GlaxoSmithKline1
Grünenthal GmbH1
Newron Pharmaceuticals SPA1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia12
Diabetic Neuropathies4
Neuralgia, Postherpetic2
Pain2
Peripheral Nervous System Diseases2
Diabetes Mellitus1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.